Philip Morris
Cigarette Smoking Pharmacokinetics and Its Relationship to Smoking Behaviour
Fields
- Author
- Darby, T.D.
- Mcnamee, J.E.
- Vanrossum, J.M.
- Mcnamee, J.E.
- Area
- REIF,HELMUT/OFFICE
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Site
- E5
- Named Organization
- Tc126
- Wg6
- Request
- Stmn/R1-071
- Stmn/R2-038
- Document File
- 2028397492/2028397799/Missing
- Master ID
- 2028397493/7798
Related Documents:- 2028397493-7494 Wg6
- 2028397495 Index
- 2028397496-7497 Background
- 2028397498-7501 United States Patent 4,256,122 Cigarette Filter
- 2028397502-7506
- 2028397507-7513 United State Patent Office 3,490,461 Cigarette Ventilation
- 2028397514-7517 United States Patent 4,331,166 Cigarette
- 2028397518-7519
- 2028397520 Response to Reports From US Testing and Fresenius Laboratories
- 2028397521-7525 Puff Parameter Analyzer Critique
- 2028397526-7529
- 2028397530 Insertion Depth Using Ppa Low Tar Brands, Perforation 10-14 Mm
- 2028397531 Insertion Depth Normal Smoking Low Tar Brands, Perforation 10-14 Mm
- 2028397532-7545 Pitfalls in the Sensory Analysis of Smoking Behaviour
- 2028397546-7547 Recent Trends in Tobacco and Tobacco Smoke Research
- 2028397548 the Kamm - Fine Holder
- 2028397549-7554 Measurements of Lip Pressure Exerted on A Cigarette During Normal Smoking
- 2028397555-7559 United States Patent 4,627,448 Tobacco Smoke Article Holder and Method Therefor
- 2028397560-7576 Evaluation of A Modified Cigarette Holder
- 2028397577-7578 Investigations Into Smokers' Behaviour A Method to Determine the Depth of Insertion on Smoked Cigarettes
- 2028397579 Insertion Depth - Brand Data 1/0.1 Perforation at 11-13 Mm, Vent 78 Percent
- 2028397580 Insertion Depth - Brand Data 2/0.2 Perforation at 11-16 Mm, Vent 73 Percent
- 2028397581 Insertion Depth - Brand Data 4/0.4 Perforation at 10-14.5 Mm, Vent 60 Percent
- 2028397582 Insertion Depth - Brand Data 4/0.4 Perforation at 11-14 Mm, Vent 60 Percent
- 2028397583 Insertion Depth - Brand Data 5/0.5 Perforation at 10-13 Mm, Vent 45 Percent
- 2028397584 Insertion Depth - Brand Data 9/0.7 Perforation at 10-14 Mm, Vent 40 Percent
- 2028397585 Insertion Depth - Brand Data 16/1.2 Perforation at 11-13 Mm, Vent 17 Percent
- 2028397586 Insertion Depth - Brand Data 1/0.2 Perforation at 13-15 Mm, Vent = 83 Percent
- 2028397587 Insertion Depth Study on 24 Brands Average Insertion Depth 12 Mm
- 2028397588 Insertion Depth - 5 Brands 1-3 Mg Tar Perforation at 10-15 Mm, Vent 60-82 Percent
- 2028397589 Response to Aubort
- 2028397590-7592 the Following Is the View of Dr. Gio Gori of the Franklin Institute, Which We Feel Is Particularly Relevant to the Subject of in-Mouth Sampling Experiments
- 2028397593-7603 A Critique of Dr Aubort's in-Mouth Study
- 2028397604-7614 Effect of Sampling Location on the Measurement of Smoke Concentration in A Glass Model of the Human Mouth
- 2028397615 Effect of Point of Sampling in A Glassmouth
- 2028397616 Effect of Point of Sampling in A Glassmouth
- 2028397617 Relative Human Uptake
- 2028397618-7621 Steady-State Concentration of Cotinine As A Measure of Nicotine-Intake by Smokers
- 2028397622-7632 Smoker Intake From Cigarettes in the 1-Mg Federal Trade Commission Tar Class
- 2028397662-7664 Development of Machine Smoking Parameters for Measurement of Cigarette Tar Yield in the United Kingdom
- 2028397665-7680 A Psychophysical Study on the Effectiveness of Cigarette Filters
- 2028397681-7685 A Paired Comparison Test Procedure for the Sensory Evaluation of Strength of Flavor and Ease of Draw of Cigarettes
- 2028397686-7736 Prediction of Secondary Vortex Flowfields Generated by An Interacting Multiple Free-Jet Configuration
- 2028397737-7740 Litigation
- 2028397741-7750 Decision
- 2028397751-7762 in the Matter of: the Corporation Philip Morris Belgium, Having Its Corporate Headquarters at 189, Chaussee De La Hulpe, Brussels 1170, R.C. Brussels No. 252.268, Plaintiff, Appearing Through Me Louis Van Bunnen and Me Jean-Pierre Van Cutsem, Attorneys. Against: the Corporation Bat Benelux-Odon Warland, Whose Corporate Headquarters Is at 38, Rue De Koninck, Brussels 1010, Defendant, Appearing Through Me Antoine Braun and Me Thierry Van Innis, Attorneys. A.C./2.290/83.
- 2028397763-7773 En Cause De: La S.A. Philip Morris Belgium, Ayant Son Siege Social Chaussee De La Hulpe, 189 A 1170 Bruxelles, R. C. Bruxelles No. 252.268, Demandresse, Comparant Par Me Louis Van Bunnen Et Me Jean-Pierre Van Cutsem, Avocats. Contre: La S.A. Bat Benelux-Odon Warland, Dont Le Siege Social Est Etabli A 1080 Bruxelles, Rue De Koninck, 38, Defenderesse, Comparant Par Me Antoine Braun Et Me Thierry Van Innis, Avocats. A.C./2.290/83.
- 2028397774-7785 En Cause De: La S.A. Philip Morris Belgium, Ayant Son Siege Social A 1170 Bruxelles, Chaussee De La Hulpe, 189, Appelants, Representee Par Maitre Louis Van Bunnen, Avocat A 1180 Bruxelles, 234 Avenue Coghen Et Par Maitre Jean-Pierre Van Cutsem, Avocat A 1000 Bruxelles, 2 Rue Brederode. Contre: La S.A. B.A.T. Benelux, Etablissement Odon Warland, Ayant Son Siege Social A Molenbeck St. Jean, Rue De Koninck, 38, R.C. Bruxelles, 8.338, Intimee, Representee Par Maitres Antoine Braun Et Thierry Van Innis, Avocats A 1200 Bruxelles, Avenue De Broqueville 116/Bte 10. Audience Publique Civile Du: 850706 R.G. No 1212/83 Arret Definitif
- 2028397786-7796 in the Suit 1. Philip Morris Gmbh, Fallstrasse 40, 8000 Munich 70, Officially Represented by Its Directors, Staffan Gunnarsson, Dr. Dietrich Flugs, Berndt Heider and Gunter Wille, and 2. The Limited Partnership of H.F. & Ph. F. Reemtsma & Co., Represented by Its General Partner, Reemtsma Cigarettenfabriken Gmbh, Which Is in Turn Represented by Its Directors, Dr. Horst Wiethuchter and Wolf Schulemann, Parkstrasse 51, 2000 Hamburg 52, the Plaintiffs, Represented in Court by: Attorneys Klaus Storch, Dr. H. Schwanhausser, Dr. H. Eichmann, Dr. B. Von Linstow, and Gerhard Barth, Mauerkircherstrasse 8, 8000 Munich 80 Versus B.A.T. Cigaretten-Fabriken Gmbh, Officially Represented by Its Directors, Dieter Von Specht and Gunter Uhe, Alsterufer 4, 2000 Hamburg 36, the Defendents, Represented in Court by: Attorneys Rainer Klaka, Dr. Michael Nieder, Guido Diemer, Dr. Christof Kruger, Delpstrasse 4, 8000 Munich 80, Concerning A Petition for An Order to Cease and Desist (Unfair Competition Law) Decision Docket No. 019149/64vi
- 2028397797-7798 Barclays
- Author (Organization)
- Clinical Pharmacokinetics
- Univ of Nijmegen
- Univ of SC
- Univ of Nijmegen
- Litigation
- Stmn/Produced
- Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- ndb24e00
Document Images
Ci`arettr Smoking Phannacokinetics
Trble V. BrandsmoKrg senedtiN used in the studjr by Prxi and
Lynch (tse31. a.spo«aants,wrare rq,.ad fnom fmacers a,ut-
trabw dsliv.ryixands for a perod ot'at Nast 3 mtxths. They
smoked mae; iran a,Wcic of oqanns per day. Ttte average
aaity consumption was 30 c+9#retta
Weeks
1 24 3 .i S 6 7'
A
8' A
8 8
A 8
A li
A C
C C
C
a flespondengs' drstanary bnM. The sequence ii -wewtk .rcerxaK.
of smokets who are free of most experimental in-
}luences on their smoking behaviour in that they
smoked lover 7 weeks in their natural environment
Thus, this matched-paindd design study with
cigarettes that am very similar in tfieir, yields, and .
with smokers who did not alter their smoking be-
haviourwith ~brand change, provided evidence that
a minimal increase in nicotine y]eld will be accom-
panied by a proportional I increase in i nicotine up.
take. Table IV shows the results of a regression
analysis for the datai obtained by'Gori and' L.yneh
('1983): [These investigators supplied, the weekly
plasma cotinine values obtained during,their stud-,
ies.] Table V illustrates the 7-week caossover and'
switch design empibyed,, and figures 2 and 3 illus-
trate the shill in the plasma cotinine concentration
curves which occurred withi the change from one
brand to another, during the 7' weeks of the study.
Determinations of plasma cotinine concentra-
tion as a marker for nicotine uptake has received
acceptance by, a number of investigators (Benowitz
et al.. 1983b: Goriiand Lynch. 1'98'3; Russell et al..
1982: Surgeon General. 1979',_ "Further, attempts
havc been made to correlate' average uptake of ni-
cotine with tar uptake using;ttte tar to nicotine ratio
denved from the standard smoking machine re-
svlts for that brand. For a given indiviidual. plasma
cotinine concentration is directlM1 related to dail%
nicotine intake under reasoii stead,-starte con-
dttnons: Howe.cri studiescompanng plasma coan-
inr.onccnirauons among tnda%tduals -,th dtlTrr-
445
ent smoking behaviour should take into accounti
the many factors which would alter, the plasma co-
tinine concentration obtained from a given daily,
uptake of nicotine. Table IiI presents the equations
which relate plasma eoanine concentration to up-
take of nicotine,,tJonversion of nicotine to aotinine.
and dearance of cotinine.
The relationship between tar and nicotine yield
of the cigarette in the smoking machine test is al-
tered! by changes in puff volume, puff frcquency,.
as well as many other factors ('Wyndtr and Hofi
mann, 1%7): Thereibre, it is unreasonable to at-
tempt to relate smoke delivery of tar to piasmalCo»
tinine concentration measurements.
100
eo
60
r
I
I
Btana 8 smdcers
0
1U 100 1000
tnog;pturna ooto+ne cancennauon (nglrtr)
Fiy. 2 Fi.erlysncy Ci!stnDutlon plot , for the loq', pasma oowtine
cancenmration of 1be:206 responaents!a the stuCy by Gon and
Lynch p19881. The loq plasma oohnwre eoncentraaon for each
subpct,was pbaed!tor each w..k o1 the stuCy, TtThe lerna/bs
anditne mates inttus qrapn,were smokers of brand 8': tfrere-
tore truey smohed itr>ar own brand (stanOard'srtakng machine
re1d. o.10my nwcotmee and, 1.Ortg i tarl for 2weeks: Tttey. 1Mn
switched to brand "A'. which ts ramcer! as a 0" 18mg ruconne and
t.Ortgitarbra/W..lor.3 weeks. This awrton,rs accomparnea1 byan increase in plasma . cotMUnie Ior 75%
ot, the smohers. TAe i
rncrease n plasma coonme was' essentially paraNN: therefore
tf1esmolier did not change peruntAe rankw.g" n thehequency
aistnbutiOn The 3, curvesstahe0 to, a+e.rqnt* representmq a"her pasma counine concentration at eaen
percentiN tevet
wnqn~was oGta,nea during ttw" period ol.smokiryibrand 'A'
After 3 , weeks the smoRers changed to i brand "C which had
smokmqimacrnne ratings ol'O~tmq ni¢oune and 1.0'nq~tar. Tne ~,
pWasma~cotinme~.concentrabon~.r,elmuceG to~.nearo trN va,ues.OD:~
ca.inea toa orano 8i
IV
W,

Cigarette SmmkinZ,Pharrnacokinetics
fml
Brard A vnokers,
oih- ~ I ~ ~
10 1oo t
Log piasma oomuu oona+maoion (nyrrh
Fis.3. frsqo.nc~/ Qistrtuh'on plott for the respondenta who
smok'eo brand 'A' (aN fq. 2'INyenil N,tlrs Case they smokad
n*0 own brand for 2.eeks2 rne toq,a the ptasma cor:,i,e
oonceraraoon for tnis puiod , is seen in ttw 2' plots which aie
stwfted to thergtu: anaoaorg,a ttiynsrpasma toteww aorxen-
trati«, a,r.g w: pa w. turiny tne l weeks of, smil the
brands wtn tne tow.r nicotine rauny, the ptasmr a>orrrr ool
centraoons were rea,oed. In both tne asa plot of rqura 2 and
in ws oat: the urft in'rne paama,cobnne ooneMaaoon at per-
cenMe bvels,wnic~ are 1 standard deviation eacA sitle of the
mean an snwar to ane change one wal fxeacs'easee upon
the raoo ot'tne uanoara smoking ratings for tnesebranCs. The
pas frwa fiyurea 2'ana 3!snow eacsa«x'oomparaor, in tnat
the vak'ues am vnCrn 10% tor each peraentile Mvel'for the 2
groups of smokers: The slopes of the regression rr,es given in
table IV and the data trom these fgures provide evidemce that
smok+ng: machine yislds are inportant to human uptake.
6. Conclusions
Since the early 1950s. two important changes
have occurred in the manufacture of cigarettes in
the United States. Firstly, the length of the cigar-
ette has increased to at least 85mm; thus there is
greater tobacco ffltratimn of mainstream smoke -
the smoke which is taken into the mouth. Sce-
ondly. filters have been added to the tobacco rod
which h'a.e'reducedlnomtal tar, yie111s from 30mg
to 17mg. according to results obtained with the
standard smoking machine test. The low tar cig-
aretac's share of the market has increased. The
viclllx oC,:garcttcs considered to be 'how tar' rance
446
from 1 Sntg down to 110mg tar. Remttly; cigarette
brands which incorporate air dilution into the'filter
ha ve been introduced onto the marketplace. These
filters dilute the mainstream smoke by up to 85%:
This procedure markedly reduces the standand'
smoking machine: yields of the ingredients of
smoke. The particulate represents approximately
8% of the mass of smoke. Even when puff volumee
is largethemariaed dilution obtained'with the highly
ventilated cigarettes greatly reduces the concentta-
tion of the particulate in l smoke, , and while an in-
creased puff volume and puff fnequency, by the
smoker may increase the intake from 1 the ulttalow
cigarettes~L the'redueed concentration of tar in the
smoke may be very'important to lung irritation and
other health considerations.
6.1 Difficulties in Rrlating, Reduced Cigarette
Yields to Improved' Health Status
While there is dose-response evidence that the
reduction in cigarette deliveries from, 30mg tar to
around 15mg tar has been accompanied by a de-
crease in the incidettce' of those distases reported
to be increased in the smoking population over non-
smokers (Kattnel. 1981;'Kramer et aL, 1983): bene-
fits which may be deri ved! from further reduction
in cigarette yields to lmg tar havenot'been eval-
uated. Both the time required for development of
any changes in the health status of smokers related
to the reduced measured cigarette machine ,vield,
and the difficulty of determining specific risk fac-
tors (given the variety of'hazardk in the human
environment) have prevented adequate evaluation
of this change. The percentage of' the population
who smoke the ultralow delivery, cigarettes is also
very small. However, when yields of cigarettes are
reducedlto theseverM1 low valuesm it is obvious that
the ,measurement 'techniques used to assess human
uptake will neeid' to become more sensitive. The
simple practice of the recording of smoker or non-
smoker., number of packs smoked per dan, and
possibly the labelled tar and nicotine content will
not be'suffictenr in epidemiolop studies which at-
tempc to dKtcrmone the intliieatce of reduction in
smoking machine test vicJds on changcs in thr

Cigarette Smoking Pliarmacokinctics
smokers' health status either on an individual or
population basis.
The classic 't' test and calculations of p values
with large standard deviation for the population
can cause sampling errors to appear as significant
results. Care must be taken to define the' popula-
tion and the distribution, especially since many
distributions are not 'normal' (bell-shaped). Like-
wise: regression analysis has many pitfalls.
Mouth delivery of smoke has little meaning in
terms of human uptake of smoke ingredients. The
acid pH of cigarette smoke, the amount of'nicotine
iw the smoke and' the limited absorptive surface
area prevent absorption of nicotine in the mouth.
Thus: puff volume has very limited meaning, es-
pecially when one considers the differences in, ex -
haled volumes. lke amount of smoke inhaled is
more important, but here air dilution, breath hold- .
ing, physical and! chemical considerations of the
product used, and! indiiridit,al' factors such ~ as tidai'
volume and vital capacity all have substantial-ef-
fects on uptake of the ingredients of smoke_
While nicotine accounts for only a small amount
of the mass of smoke;, it~ represents approximately
10% of the particulate mass. Nicotine is a major
biologically active compound and~has been exten
siwely studied, both as aphartnacoletgial!agent and
as an ingredient of'smoke. However, when one re-
views, the literature related to cigarette smoking;,
many of the experiments are disappointing in, thar
considerations of pharmacokinetic parameters were
not included in either the experimental design or
the conclusions. Many of the experiments compare
single blbtDdl levels obtained a few minutes after
smoking a cigarette. With a compound like nico-
tine. where tissue distribution is rapid and half-life
is short. naturalls, the blood level is more depend-
enu upon rate of uptake and clearance than it is to
amount of nicotine taken up. Steady-state condi-
tions such as those obtained through continuous
infusion are nou reached.
Carbon monosidr has been used as ai measure
of uptake of the gaseous phase of smoke (Surgeon
General. 1'0'9)i Since the particulate iscontaincd
wuthun thu gasoous phase. this would seem to bc a
satistuczon measure of uptat.c oLsmol.c. HuNr% rr.
4477
physiological factors such as exercise and environ-,
mental factors such as automobile exhaust can al-
ter individual carbon monoxide values. While car-
bon monoxide values appear to correlate well with
individual plasma cotinine concentrations, this
correlation reduces as corrections are made in the
analysis for common factors in both measure-
ments. such as bodirwright and ~ number of cigar.
ettes smoked per day. Population studies using av-
eraging techniques suffer from the wide variations
in: background kvels of carbon: monoxide and in-
dividual activity patterns as well as' differences in
other parameters that can affect carbon monoxide
values.
6.2 Recommendations !br Future Studies
Measurement'of'daily uptake of nicotine by in-
dividuals smoking in their ouvn~ naturall environ-
ment is best'accomplished'by use of measurements
of plasma cotinine concentration. The better esti-
mates of'cotinine li.alf4ifa of'near 15 ' hours from
the previously repotted'. value of 30 hours (Surgeon
GeneraL 1979) increases the need for care to en
sure that as near steady-state conditions as possible
are reached'at the time the blood samples are ob.
tained for determination of plasma cotinine con-
centration. If' comparisons of brand' yields are to
be made. a matched-paired design should be used,
and the study should be carried out over saveral'
weeks. Daily consumption of cigarettes should be
obtained: this can be done by req}tiring a diary or
cigarette butt collectionl While these procedures will
unduli inform the smokers, of their cigarette con-
sumption and hence may affcct smmking, behav-
iour: in a matched-paired design with proper cross-
over experiments this factor should be constant for
the individual. Where there are marked differences
in weck-to-week plasma cooinine values or where
there are marked differences in the dailg con-
sumption data without' corresponding changes in
plasma cotinine concentrotion. the dhta should be
suspect. Data comparnsons should'be made undcr,
rclattcei% sumilar, cconditions for the individual.
Naturall%, diQfcrcnccs in smoking bcha% tour, that
acaompa m a brandl change arc meautingttill but'

Cig,arotte,Smokin` Phamucokinetics
changes in smoking behaviour while smoking a
single brand should be carefully evaluated if the
intent of the study is to make brand comparisons.
Plasma cotinine concentrations can be used to
compare standard smoking machine yield with hu-
man uptake. as was done by Benowitz et al. (l9g3a).
These experiments are more di fficult to control
since major differences in btands ean affect uptake
by the individuali and thus affect clearance and
metabolic conversion of nicotine to cotlnitle:
Brands, with very similar standard smoking ma-
chine'yields of nicotine and tar - where air dilution
characteristics and smoke pH are'similar - would
be! expected to have' similar uptakes of nicotine.
Therefore, plasma cotinine concentration would
serve as a marker for average daily intake ~ of ni -
cotine (Gori and' Lynch, 1983). Where there anr
differences in numbers of cigarettes' smoked dailyfor a given individual, this would' naturally
alterr
determinations of individual cigarette delivery.
Changes in daily consumption ane important' in
compensatiow considerations. Similarlit, individ-
ual metabolic differences, as reponed i by' Benowitz
el' al. (1982a) and Hertung et al. (I983) also need'
to be taken into account in the individual differ-
ences in plasma cotinine concentration following a
given daily dose of nicotine. It appears that about
50% of the'difl'erences in plasma cotinine concen-
trations among smokers can be explained by' dif-ferences in metabolism and 50% due to smoking
betiaM17our difFenences, incltiding' brand selection.
Smokers of the ultralow yield brands have average
plasma cotinine concentrations that are about31J9b
below those ofithe more popular brands: These in-
dividtrals would also benefit from a marked re-
duction in'particulate concentration in'the inhaled
s'm oke:
References
alticrs. R-E.. Pcterson Jr. H.T:. Bohnmg- D E. and L,opmann. %1.:
Shuntorm etTc,-ts of etgaronr.smoktn(,on ~bronchul i.lcaranuc.
in humans, k.rmnevoi En.uonmcnut Hnlth 3G 3di1-36'-
ttV-st
armimgc: a'i:. Bl.wd Ic.-ds'.o(mcotma and .-ountnc achtclcd
dunncsmut<mc. in C.ntrdl i1a1 tEdta \.cnunc N.wknh.rp Bcr.
t:uer'ru* f~rvrr,cvnunr'> :>n
448
Arrmtage. !CK:: Dolkm. C_T.:,('seofse: C:F::' Housrnun. T.H!:
tkwsPJ. and'Tumer. D.M_:Abwrytron'and metabolism of'
nicoune ftom,esprettes. Bntnh Medical Journall4: 3'13-316
(t97s1.'.
Austin. E`_ lirock. l. and Wisskr. E: A model for deposition of
stable and unstable aerosols in i the human resprratornr tran.
.#meriran Industna! H.yene Association Journal 40: 1055-
1066Yi19991.i
9tnowitz NiL:~ HaA S.M.: Herain4 tLt.: Jacob. P:(II1): Jones.
R.T: and Osma>L A.-[..: Smokers of tow-.ietd~ ciprettes do
not constune kss nicotine. New'England Jourml of 1Ml+dicine.
JO(r 139-1K2 (i19iDat.
Benoritz,N.L: J.oob. PJ(ttth Jones. R.T'. and Rosenber. J::
Intaindividual .ariabitity in the metabolism,and cardio.as
cular effecu of iaicocine'in iman. Joumat of Phannaootogy'and
Exqecimental Thesapeuties' 221: 3153:372 (19M1.
lienovntg N S Kiryr F. and Jaaob P.tlllt Cireadian blood' ni-
cotine eonoenuations durinZ cigarette smokin4 Clinical
Pharmaoology and Thenpeutia 32: 758=76i{ (t9b2aL
tte,wWita. NeL; Kuyt. F.; Jacob. P:(Itlt: Jones. R:T, and Ounan.
A.-L: Coanincdispositioa and klktts, Ctinin! IPharmaeology
and Therapcuucs 34' 604-611 (19d3b1.
Brain. l.D: and vafber6. P_#: Di!posttion of aerosol in the res+
piracory tract. American Roriew ofRespintory Disease 12P
1325't373 (1979/.
Breimer: D.D.: tnuxindi.iduat variations in drug dispositioa.
Clinical impliouons and nMethods'of'inrestigatlon. Clinical
Pliarmaeoktneacs 8: 371-377 p1983).
Cohrn. #1. and Roe. F:J.: Monograph on the pharmacology and
toxicotugy of n><ounc: tkcasional Paper No. 4 (Tobacco Ad-
visorrCounciL London 19H11.
tDarb..,T.Dw Phannacologic considerations in the design of'toaf iaology experiments. Clinicat
Toaieotop I:. ="9-238 (197b):.,
Doll- R: and Peto. R.: Cigarette smoking and' bronchial carai-
noma: Dose and time trlationships among regular smokerss
and lifiilortg non-smokers- American Journal of E.ptdcaniolaty
and Community Health 32' 303-3t3 (1978)
Garfink'cL L:,Chanpcs in number of cig;rettes smoked compared
to changes in tar and nicoune content over a 1}vear'pcnod:
in Gon and Boek (Edst ASak Cigareste'..,pp.19-.4 (iBanbunRepon /31. Cold Spnng Harbor Laboratory.
Cold Spring Har-
boc vl" 198tC1.
GuWborg. LS and Smith. R:B.:.SetUmg,and'ddTustoniofaerosol
panu+les tn, small atrrvau-s dunng breath holdrng. Annals of
Bromadtcal'.Enp.ncenng,,9; 557-535 i I1V811.
Gu/dstnn, i:L and i:apman. S.M.: Prnncipks'.ofdrug',actton: the
basis ofpharmacoingg . _'nd ed. (J' N-tk% and.Sons: :+1hw .S-nrl'
19141
.
Gun. G IB'. and Lrnih ('J_: SmoFcr rntai.e from ctgarenes in the
1-mg Ftdcral Tra.fe'Fummtsston tar elass. .ccgulir Tutueol-
ogp and Rharmacul.rg% 7.. n lttJ'Q q I V33t
G..nod. I'N Th'ae es.Troon andd mctafw4Wsm n1 imcotmr and somc
min.tr taEucco.all,afotda in man..&+araNC.tur. Tatvll2xshunR.
t..u,rrn \1 k t hcm.ull.,omNru.>n.t:iNattc.m..kc'tnr~...n

Cigarette Smoking Pfiarmarokinetics
and BocktEds) a,Sak CiBarene?. pp.19(-203 (Banburx Re-
pon t 31. CokllSpnng Harbor (aboratorv. Cold'SprtnB Harbor:
YY 1980L
Harns.1.E: Cigarette smoking among sucerssrve'birtL cnhorts of
men and .omen in the Umted',States during 1900-80. Jourtnl
of the N'luonal Cancrr Instttute,71:,a73-479 (A983).
HennmBR.L:Jotas. R'.T.: Birttotritz N.L and IMines.A:H.: How
a cnptetse',u'smokedidtlerrnines,blopd nicotine k+rt(a Clinid
Phamucolosy and Therapeuties 33: 849A ()983ti
H)ern. L: Ciprene stnoke. tarand nicotine kve(s in S..eden dur-
ing the decade 1964-1975. Pnoeeadingt of tMe 3rd Wor1d Con-
krence on Smoking and Halth: Modifwin8 the Risk for the
Smoker. p,p.97.1021DHEW Publieation No. (NIH176t221.
19,76L
Hoficker. C.F.: Abuse of uatistioi paeka8es: Theease ofUie Ben-
eral Ilinar'tnodd. .#metion Journal of PAysiolo{y 245 (SuppL
Regulatory lntepau.e'Camp.,Phsiol 1Kk R249-R302 (1983).,
Holmbc% R.w':: Deternumtionof partick size intoEacco smoke
inhalation expowee dtvioes,usia8 meehykyanoaerylate 6ica-
tion and scanning rttieroseopln in Guerin and Griffith (Eds1
Tobacco Smoke Inhalation Bioassay Chemiury, pp:11D3-118
(ORNL-Ss_#. Oak Ridge National LaboratorNOak RidBe.
Tennessec 1979).
Kannel K.B_ l'pdiue on the rok otciprctte smoking in ear-
onarr, artorv disease. American Heart, Journa( I 101: 319:3r8
(19811
Keith. C.HJ: Eapenmenta( and' theoretical aspects of'oi8aroae
smoke filtration: in Deitx 4Ed.) Removal of Traa Conumi-
nants from the >tr: pp:79-90I(ACS S)znposium Series No. 17.
1975).',
Keith_ C.H.. Phyucaf mctlwds for the modification of tobacco
smoke: in Gon and'Bock (Eds) A Safe Cigarette?. pp:?5:237
(Banburn,Repon (31.' Cold Spring Harbor Laboratory. Cold
Spnna Harbor. Y'1- 1980).
Knmer_ 1.11: F:ita:ume. H.: Proudfit: W'L: Matsuda: Y:: Wi1-
liams. G.wW and'Sones 1rF.N.: ProBression and regression
ofcoronarn atherosakrwsts Relauon tonskfactors A'menican
Heart loumal',105 1JJL1W (i1983).1
Kunre. M- and.Vutuo. C.:. Threshold oftar eaposure: Analysts ofsmokmE htstoryof mafc lung cancer
cases andlcontrolt: in
Gurn and Bock.UEdst.1. Safe CiBarette. pp_'9-3J (Banbury.
Rbpon (I1. Cold'Spnng Harbor Labontory,, Cold SpnnB,Har-
bor: \}'I`7901:
L.nch: G.1 andiGon. G.B.: vondctectablr nskieveli in cigarette
smokanE- in Gon and Bock 1Eds1 i Safe Cijarente" pp.37-i3
t Banburc Rcpont)). Cold . Spring ~ Harbor Uaboratorn, Cold
SpnnE,Harbor, `l' 19801.
4G9'
McKcnnts Jr. H.: Eapenmenul considbrauons of some alternate
toutn ia the mammalian metabolism of eicotine. Beitrape
aur,TabakforsAunB 8: 388-=89 (i1976'L
Ro.dand M. and Toaer, T:N.: Clinical Pharmacoluaetics Con-
cepts and,Applicatrons (Lea and Febiar.,Philade(phia 1980).
RussNL M1A H; Suttoa SR.:,Iyer: R::,Fe.erabend. C and!Vaey,
CJ::,LotK term switching to low ur b.., ttieotine ci8atettes.
Bnush Journal IofiAddtction 77: 145-1'S8'(i198B):
Schrovelbeia , H:: A'bsorytqn of' nieotino under various condi-
tions. Beitra8e aw Tabakforshung 8: :86_87 (II9761,'
Schmeltz L(Ed.Ic Chemistry of'Tobaeoo and Tobacco Smoke
(Pkaum Piess Ne+. York 19721.
Sdke: W.Ak and Mlthe.z J.H_ TAe :permcabiHty ofci8areae p-
pers and cigamtte ventilation. Beitra8e :ur Tabak'forsaNunB
lattrnational!9:' 193-200(19781.
Suryeon Goneral:, Stnokin8,attd Hwlth: A,rt:port of'the Surgeon
General U.S: Depastment~of'HealtL. Education and We(farr
Publication No. (PH5) 79-5006'6' (1979):
Tobin. MJ1 and Sackner- Mi.l: Monitorine smokitt8,patterns of
low and high tar ciprettes with induaive pledi.smograpfoy.
Americoa Rbvie.rof Resptratory, Disease 126: 25E-26A (19821
Turnrr. , D.M.: The use of a radiocbomia( method to study the
metabolism iof nieotiiro in experimenul,animafs. Bcitra8e zur
Tabaktacachun8 Bi 391 i (19761.
VescdL ES: and Pimtp, M.B: Auessment,of,rnetbods to identify
sources of iiuerindividual pharmacokineuc'variauotts: Clinical I
Phamuaokinetia 8: 378-409'(19831.
M'aW. N,': Doll. RL and Copeland. G.: Trrndt in tar. atcotine: and i
carbon ~monoxide yields of UK ciganettes tnanu6ctured since
1934. British Medical Journal 28"_- 76'3-765 (19811:
Wrodor. EL Some concepts of the,kss Aarmfu( ciprette: m Gori
and Bock (Edsl A Safe C4xrette?. pp.3-1= (Banbury Rbport'
(31: Cold Spring Harbor; Laboratory: Cold Spring Harbor: PtY
19801.
Wynder. EL and' HoRman. D` Tobacco and Tobacco Smoke,
tAodcmic Press. New York 1%71.
Yeh. H C.: Phakn. R.F. and IRaabe. OiG.: Factors influencing the
deposition of inhaled particks: Environmental Ha1th Per-
specuves Ii: 1a7-156 (I19761
Yu. C.P.: A two component theory of aerosol',deposvuonin luna,
au..ayi Bulletin of \tathemaucal Bwlbap a0: 693:706 (1I978):
addtrss for eorrespondence and re+pmms: Dr T D: DarM. Dc-
panment of Pharma¢olo(t., School of Sted.ctnec.. l4m.rorsnyofSouth Carolini Columbia. SC 29208
t1'S>I
